Vitamin D status and ill health--author's reply

Philippe Autier, Mathieu Boniol, Cécile Pizot, Patrick Mullie

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Giovannucci enquires whether intervention studies were long enough to allow full expression of health benefits associated with high serum 25-hydroxyvitamin D (25[OH]D) concentrations. Recent meta-analyses that compared top to bottom quantiles of 25(OH)D found summary relative risks of 0·67 (95% CI: 0·59–0·75) in 16 studies of type 2 diabetes1 and of 0·66 (0·54–0·81) in eight studies of colorectal cancer.2 We plotted relative risks of diabetes and colorectal cancer occurrence reported by prospective studies against follow-up duration (figure).
LanguageEnglish
Pages275-276
Number of pages2
JournalThe Lancet Diabetes & Endocrinology
Volume2
Issue number4
DOIs
Publication statusPublished - 1 Apr 2014

Fingerprint

Vitamin D
Health Status
Insurance Benefits
Meta-Analysis
Colorectal Neoplasms
Prospective Studies
Serum
25-hydroxyvitamin D

Keywords

  • intervention studies
  • vitamin D
  • vitamin D deficiency
  • ill health

Cite this

Autier, Philippe ; Boniol, Mathieu ; Pizot, Cécile ; Mullie, Patrick. / Vitamin D status and ill health--author's reply. In: The Lancet Diabetes & Endocrinology. 2014 ; Vol. 2, No. 4. pp. 275-276.
@article{fcffc21bec944e59a2e4d8ee630acbef,
title = "Vitamin D status and ill health--author's reply",
abstract = "Giovannucci enquires whether intervention studies were long enough to allow full expression of health benefits associated with high serum 25-hydroxyvitamin D (25[OH]D) concentrations. Recent meta-analyses that compared top to bottom quantiles of 25(OH)D found summary relative risks of 0·67 (95{\%} CI: 0·59–0·75) in 16 studies of type 2 diabetes1 and of 0·66 (0·54–0·81) in eight studies of colorectal cancer.2 We plotted relative risks of diabetes and colorectal cancer occurrence reported by prospective studies against follow-up duration (figure).",
keywords = "intervention studies, vitamin D, vitamin D deficiency, ill health",
author = "Philippe Autier and Mathieu Boniol and C{\'e}cile Pizot and Patrick Mullie",
year = "2014",
month = "4",
day = "1",
doi = "10.1016/S2213-8587(14)70049-X",
language = "English",
volume = "2",
pages = "275--276",
journal = "The Lancet Diabetes & Endocrinology",
issn = "2213-8587",
number = "4",

}

Vitamin D status and ill health--author's reply. / Autier, Philippe; Boniol, Mathieu; Pizot, Cécile; Mullie, Patrick.

In: The Lancet Diabetes & Endocrinology, Vol. 2, No. 4, 01.04.2014, p. 275-276.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Vitamin D status and ill health--author's reply

AU - Autier, Philippe

AU - Boniol, Mathieu

AU - Pizot, Cécile

AU - Mullie, Patrick

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Giovannucci enquires whether intervention studies were long enough to allow full expression of health benefits associated with high serum 25-hydroxyvitamin D (25[OH]D) concentrations. Recent meta-analyses that compared top to bottom quantiles of 25(OH)D found summary relative risks of 0·67 (95% CI: 0·59–0·75) in 16 studies of type 2 diabetes1 and of 0·66 (0·54–0·81) in eight studies of colorectal cancer.2 We plotted relative risks of diabetes and colorectal cancer occurrence reported by prospective studies against follow-up duration (figure).

AB - Giovannucci enquires whether intervention studies were long enough to allow full expression of health benefits associated with high serum 25-hydroxyvitamin D (25[OH]D) concentrations. Recent meta-analyses that compared top to bottom quantiles of 25(OH)D found summary relative risks of 0·67 (95% CI: 0·59–0·75) in 16 studies of type 2 diabetes1 and of 0·66 (0·54–0·81) in eight studies of colorectal cancer.2 We plotted relative risks of diabetes and colorectal cancer occurrence reported by prospective studies against follow-up duration (figure).

KW - intervention studies

KW - vitamin D

KW - vitamin D deficiency

KW - ill health

UR - http://www.thelancet.com/journals/landia/article/PIIS2213-8587%2814%2970049-X/abstract

U2 - 10.1016/S2213-8587(14)70049-X

DO - 10.1016/S2213-8587(14)70049-X

M3 - Article

VL - 2

SP - 275

EP - 276

JO - The Lancet Diabetes & Endocrinology

T2 - The Lancet Diabetes & Endocrinology

JF - The Lancet Diabetes & Endocrinology

SN - 2213-8587

IS - 4

ER -